Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: Insights from NMR mapping studies and site-directed mutagenesis

被引:30
作者
Shekhtman, A
Ghose, R
Wang, DX
Cole, PA
Cowburn, D
机构
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[3] New York Struct Biol Ctr, New York, NY 10021 USA
关键词
protein tyrosine kinase; SH3; domain; Src-family kinases; heteronuclear NMR;
D O I
10.1006/jmbi.2001.5126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Csk (C-terminal Src kinase), a protein tyrosine kinase, consisting of the Src homology 2 and 3 (SH2 and SH3) domains and a catalytic domain, phosphorylates the C-terminal tail of Src-family members, resulting in downregulation of the Src family kinase activity. The Src family kinases share 37% homology with Csk but, unlike Src-family kinases, the catalytic domain of Csk alone is weakly active and can be stimulated in trans by interacting with the Csk-SH3 domain, suggesting a mode of intradomain regulation different from that of Src family kinases. The structural determinants of this intermolecular interaction were studied by nuclear magnetic resonance (NMR) and site-directed mutagenesis techniques. Chemical shift perturbation of backbone nuclei (H' and N-15) has been used to map the Csk catalytic domain binding site on the Csk-SH3. The experimentally determined interaction surface includes three structural elements: th N-terminal tail, a small part of the RT-loop, and the C-terminal SH3-SH2 linker. Site-directed mutagenesis revealed that mutations in the SH3-SH2 linker of the wild-type Csk decrease Csk kinase activity up to fivefold, whereas mutations in the RT-loop left Csk kinase activity largely unaffected. We conclude that the SH3-SH2 linker plays a major role in the activation of the Csk catalytic domain. (C) 2001 Academic Press.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 41 条
[21]   The structure of the IgE Cε2 domain and its role in stabilizing the complex with its high-affinity receptor FcεRlα [J].
McDonnell, JM ;
Calvert, R ;
Beavil, RL ;
Beavil, AJ ;
Henry, AJ ;
Sutton, BJ ;
Gould, HJ ;
Cowburn, D .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (05) :437-441
[22]  
OKADA M, 1991, J BIOL CHEM, V266, P24249
[23]   THE CD4 RECEPTOR IS COMPLEXED IN DETERGENT LYSATES TO A PROTEIN-TYROSINE KINASE (PP58) FROM HUMAN LYMPHOCYTES-T [J].
RUDD, CE ;
TREVILLYAN, JM ;
DASGUPTA, JD ;
WONG, LL ;
SCHLOSSMAN, SF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5190-5194
[24]   Possible v-Crk-induced transformation through activation of Src kinases [J].
Sabe, H ;
Shoelson, SE ;
Hanafusa, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :31219-31224
[25]   ANALYSIS OF THE BINDING OF THE SRC HOMOLOGY-2 DOMAIN OF CSK TO TYROSINE-PHOSPHORYLATED PROTEINS IN THE SUPPRESSION AND MITOTIC ACTIVATION OF C-SRC [J].
SABE, H ;
HATA, A ;
OKADA, M ;
NAKAGAWA, H ;
HANAFUSA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3984-3988
[26]   ACTIVATION OF C-SRC IN CELLS BEARING V-CRK AND ITS SUPPRESSION BY CSK [J].
SABE, H ;
OKADA, M ;
NAKAGAWA, H ;
HANAFUSA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (10) :4706-4713
[27]   Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor [J].
Schindler, T ;
Sicheri, F ;
Pico, A ;
Gazit, A ;
Levitzki, A ;
Kuriyan, J .
MOLECULAR CELL, 1999, 3 (05) :639-648
[28]   Crystal structure of the Src family tyrosine kinase Hck [J].
Sicheri, F ;
Moarefi, I ;
Kuriyan, J .
NATURE, 1997, 385 (6617) :602-609
[29]   Domain interactions in protein tyrosine kinase Csk [J].
Sondhi, D ;
Cole, PA .
BIOCHEMISTRY, 1999, 38 (34) :11147-11155
[30]   Peptide and protein phosphorylation by protein tyrosine kinase Csk: Insights into specificity and mechanism [J].
Sondhi, D ;
Xu, WQ ;
Zhou, SY ;
Eck, MJ ;
Cole, PA .
BIOCHEMISTRY, 1998, 37 (01) :165-172